Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Ugeskrift for Laeger|March 18, 2021
[Vaccine approval during an epidemic]Kristine Moll Harboe, Nikolai Constantin BrunThe Lancet. Oncology|June 5, 2019
Master protocols in clinical trials: a universal Swiss Army knife?Thomas Sudhop, Nikolai Constantin Brun, Claudia Riedel, et al.The Lancet. Infectious Diseases|May 13, 2021
Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort studyLars Christian Lund, Jesper Hallas, Henrik Nielsen, et al.Plos Medicine|September 8, 2020
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort studyLars Christian Lund, Kasper Bruun Kristensen, Mette Reilev, et al.JAMA Network Open|July 2, 2020
Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With InfluenzaLars Christian Lund, Mette Reilev, Jesper Hallas, et al.Journal of the American Heart Association|October 1, 2020
Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort StudyChristian Fynbo Christiansen, Uffe Heide-Jørgensen, Thomas Bøjer Rasmussen, et al.International Journal of Epidemiology|September 5, 2020
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohortMette Reilev, Kasper Bruun Kristensen, Anton Pottegård, et al.Thorax|December 9, 2020
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysisChristian Fynbo Christiansen, Anton Pottegård, Uffe Heide-Jørgensen, et al.Pageof 1